ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,148.76
2.00%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biolase Inc (BIOL)

  7. Biolase Inc (BIOL) News

Biolase (BIOL)

Biolase Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOL
DateTimeSourceHeadlineSymbolCompany
08/03/202411:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIOLBiolase Inc
05/03/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
27/02/202421:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
23/02/202421:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
21/02/202421:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
21/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
15/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
14/02/202418:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
14/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIOLBiolase Inc
14/02/202401:03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
09/02/202413:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
07/02/202411:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
07/02/202411:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
31/01/202402:57Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
29/01/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
29/01/202411:30PR Newswire (US)BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024NASDAQ:BIOLBiolase Inc
24/01/202422:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIOLBiolase Inc
19/01/202411:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
08/01/202421:05PR Newswire (US)BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023NASDAQ:BIOLBiolase Inc
03/01/202421:05PR Newswire (US)BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
29/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
26/12/202322:22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
20/12/202319:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIOLBiolase Inc
14/12/202321:05PR Newswire (US)BIOLASE RECEIVES TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
12/12/202321:05PR Newswire (US)BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser TrialNASDAQ:BIOLBiolase Inc
08/12/202314:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
08/12/202314:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIOLBiolase Inc
06/12/202318:46PR Newswire (US)BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIOLBiolase Inc
17/11/202321:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
09/11/202321:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOLBiolase Inc
 Showing the most relevant articles for your search:NASDAQ:BIOL

Your Recent History

LSE
SCLP
Scancell
LSE
AGL
Angle
LSE
EEE
Empire Metals
LSE
FUM
Futura Medical
LSE
AAU
Ariana Resources
LSE
PHNX
Phoenix
LSE
SCE
Surface Transforms
LSE
GFM
Griffin Mining
LSE
HARL
Harland & Wolff
LSE
AAZ
Anglo Asian Mining
LSE
JEMA
Jpmorgan Emerging Europe...
LSE
TERN
Tern
LSE
MIN
Minoan
LSE
BEN
Bens Creek
LSE
CNR
Condor Gold
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved